D&P Bioinnovations, LLC

An implantable, bioresorbable medical device that functionally regenerates damaged esophagus within the body, avoiding the need for gastric pull-up surgery and reducing treatment costs by over $240,000 per treatment.

The company has been recognized with multiple awards including MedTech Innovator Semi-finalist status, TERMIS World Congress Business Plan Competition 3rd place, and named Best Regenerative Medicine Company in California. Their technology addresses a $20 billion U.S. annual market.